Items where authors include "Ng, W-F"

Article

Pratt, AG, Siebert, S, Cole, M et al. (13 more authors) (2021) Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial. The Lancet Rheumatology, 3 (5). e337-e346. ISSN 2665-9913

Siebert, S, Pratt, AG, Stocken, DD orcid.org/0000-0001-8031-1738 et al. (9 more authors) (2020) Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial. Medicine, 99 (26). e20458. ISSN 0025-7974

Tarn, JR, Howard-Tripp, N, Lendrem, DW et al. (48 more authors) (2019) Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials. The Lancet Rheumatology, 1 (2). e85-e94. ISSN 2665-9913

Hackett, KL, Davies, K, Tarn, J et al. (32 more authors) (2019) Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren's syndrome. RMD Open, 5 (1). e000885. ISSN 2056-5933

Fisher, BA, Everett, CC orcid.org/0000-0002-9788-840X, Rout, J et al. (24 more authors) (2018) Effect of rituximab on a salivary gland ultrasound score in primary Sjogren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy. Annals of the Rheumatic Diseases, 77 (3). pp. 412-416. ISSN 0003-4967

Dumusc, A, Ng, W-F, James, K et al. (27 more authors) (2018) Comparison of ESSDAI and ClinESSDAI in potential optimization of trial outcomes in primary Sjögren’s syndrome: examination of data from the UK Primary Sjögren’s Syndrome Registry. Swiss Medical Weekly, 148 (56). w14588. ISSN 1424-7860

Oni, C, Mitchell, S, James, K et al. (31 more authors) (2017) Eligibility for clinical trials in primary Sjögren’s syndrome: lessons from the UK Primary Sjögren’s Syndrome Registry. Rheumatology, 56 (12). p. 2255. ISSN 1462-0324

Fisher, BA, Jonsson, R, Daniels, T et al. (18 more authors) (2017) Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome. Annals of the Rheumatic Diseases, 76 (7). pp. 1161-1168. ISSN 0003-4967

Bowman, SJ, Everett, CC orcid.org/0000-0002-9788-840X, O'Dwyer, JL orcid.org/0000-0002-7212-6089 et al. (21 more authors) (2017) Randomized Controlled Trial of Rituximab and Cost‐Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome. Arthritis & Rheumatology, 69 (7). pp. 1440-1450. ISSN 2326-5191

Ng, W-F, Miller, A, Bowman, SJ et al. (26 more authors) (2017) Physical activity but not sedentary activity is reduced in primary Sjögren’s syndrome. Rheumatology International, 37 (4). pp. 623-631. ISSN 0172-8172

Howard Tripp, N, Tarn, J, Natasari, A et al. (29 more authors) (2016) Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines. RMD Open, 2 (2). e000282.

Lendrem, D, Mitchell, S, McMeekin, P et al. (28 more authors) (2015) Do the EULAR Sjögren’s syndrome outcome measures correlate with health status in primary Sjögren’s syndrome? Rheumatology, 54 (4). pp. 655-659. ISSN 1462-0324

Proceedings Paper

Bowman, S, Everett, C, Bombardieri, M et al. (15 more authors) (2015) Preliminary Results of a Double-Blind Randomised Trial of Rituximab Anti-B-Cell Therapy in Patients with Primary Sjogrens Syndrome. In: Arthritis and Rheumatology. 2015 ACR/ARHP Annual Meeting, 06-11 Nov 2015, San Francisco, CA. Wiley .